ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Hyaluronan"

  • Abstract Number: 0787 • ACR Convergence 2024

    Efficacy of Intra-Articular Hyaluronic Acid Injection for Nonsurgical Management of Carpometacarpal Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Clinical Trials

    Mohamed Abdelsalam1, omnia Samy2 and Asmaa al-Najjar3, 1Rheumatology, Rehabilitation and Physical medicine department - faculty of medicine -Misr University for science and technology, 6th of October, Al Jizah, Egypt, 2Faculty of medicine - Zagazig university, Al Zagazig, Egypt, 3Faculty of medicine - Al-Azhar university in Gaza, Gaza, Palestinian Territories

    Background/Purpose: Carpometacarpal osteoarthritis (CMC OA) is a painful condition affecting 21% of hand OA patients. Various treatment modalities have been explored to reduce pain and…
  • Abstract Number: 1203 • ACR Convergence 2024

    My Shoulder Hurts, What Should I Do? A Systematic Review and Bayesian Network Meta-analysis of Different Injectables in Glenohumeral Osteoarthritis

    Mohamed Abdelsalam1, Mona Sajed2, Aya Alsaeed3, Heba Abdelrahman4, roaa Rafat5, Mohamed Tarek6 and Asmaa al-Najjar7, 1Rheumatology, Rehabilitation and Physical medicine department - faculty of medicine -Misr University for science and technology, 6th of October, Al Jizah, Egypt, 2Faculty of Pharmacy - Al-Azhar university for girls, Mansoura, Ad Daqahliyah, Egypt, 3Faculty of medicine - Mansoura university, Mansoura, Ad Daqahliyah, Egypt, 4Faculty of medicine - Mansora university, Mansoura, Ad Daqahliyah, Egypt, 5Faculty of medicine, Ahfad University for Women, Khartoum, Sudan, Cairo, Egypt, 6Faculty of medicine - Al-Azhar university Cairo branch, Cairo, Egypt, 7Faculty of medicine - Al-Azhar university in Gaza, Gaza, Palestinian Territories

    Background/Purpose: Glenohumeral Osteoarthritis (GH OA) significantly impacts joint function and quality of life. Various intraarticular injectable treatments, including hyaluronic acid (HA), corticosteroids (GCs), platelet-rich plasma…
  • Abstract Number: 1840 • ACR Convergence 2023

    Value of Various Intra-Articular Injections for Knee Osteoarthritis Management

    Hanna Mass1, Jamie Collins1, david Hunter2, Catherine Yang1, Morgan Jones1, Stephen Messier3, Tuhina Neogi4, A. David Paltiel5, Jeffrey Katz1 and Elena Losina6, 1Brigham and Women's Hospital, Boston, MA, 2Sydney Musculoskeletal Health, University of Sydney, St. Leonards, Australia, 3Wake Forest University, Winston-Salem, NC, 4Boston University School of Medicine, Boston, MA, 5Yale School of Public health, New Haven, CT, 6Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Intra-articular injections (IAI) are commonly used to relieve pain and delay total knee replacement (TKR) in persons with knee OA. Despite higher costs and…
  • Abstract Number: 0580 • ACR Convergence 2020

    Risk of Severe Acute Localized Reactions for Different Intra-Articular Hyaluronic Acid Knee Injections in a Real World Setting

    Kevin Ong1, Jack Farr2, Louis McIntyre3, Andrew Gudeman2, Iain Murray4, Charles Hummer5, Wilson Ngai6, Heather Good7, Edmund Lau8 and Roy Altman9, 1Exponent, Philadelphia, 2Indiana University Department of Orthopaedic Surgery, Indianapolis, 3US Orthopedics, Tarrytown, 4Department of Orthopaedics, The University of Edinburgh, Edinburgh, United Kingdom, 5Premier Orthopaedics and Sports Medicine, Glen Mills, 6Sanofi US, Bridgewater, 7Sanofi US, Bridgewater, FL, 8Exponent, Menlo Park, 9David Geffen School of Medicine, University of California, Agua Dulce, CA

    Background/Purpose: Case reports of severe acute localized reactions (SALR) following intra-articular (IA) hyaluronic acid (HA) injections for knee osteoarthritis (OA) have been described. These have…
  • Abstract Number: 1652 • ACR Convergence 2020

    Progression of Knee OA with Use of Intra-articular Corticosteroids (CS) vs Hyaluronic Acid (HA)

    Justin Bucci1, Xiaoyang Chen1, James Torner2, Michael Nevitt3, Cora Lewis4 and David Felson5, 1Boston University, Boston, MA, 2University of Iowa, Iowa City, IA, 3University of California, San Francisco, Orinda, CA, 4University of Alabama Birmingham, Birmingham, AL, 5Boston University School of Medicine, Boston, MA

    Background/Purpose: Recent studies have questioned whether CS injections (CSI), a popular treatment recommended by guidelines, hasten progression of knee OA.  A recent cohort study suggested…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology